Preliminary evaluation of [11C]MAGL-0519 as a promising PET ligand for the diagnosis of Hepatocellular carcinoma.

[1]  Steven H. Liang,et al.  [18F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models , 2021, Acta pharmaceutica Sinica. B.

[2]  Steven H. Liang,et al.  Development of a highly-specific 18F-labeled irreversible positron emission tomography tracer for monoacylglycerol lipase mapping , 2021, Acta pharmaceutica Sinica. B.

[3]  Steven H. Liang,et al.  Design, Synthesis and Evaluation of 18F-labeled Monoacylglycerol Lipase Inhibitors as Novel Positron Emission Tomography Probes. , 2019, Journal of medicinal chemistry.

[4]  Steven H. Liang,et al.  Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a "Tail Switching" Strategy on a Piperazinyl Azetidine Skeleton. , 2019, Journal of medicinal chemistry.

[5]  Timothy L. Foley,et al.  Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation. , 2018, Journal of medicinal chemistry.

[6]  Lu Wang,et al.  In Vitro and in Vivo Evaluation of 11C-Labeled Azetidinecarboxylates for Imaging Monoacylglycerol Lipase by PET Imaging Studies. , 2018, Journal of medicinal chemistry.

[7]  M. Amagai,et al.  Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  Shuang Liu,et al.  Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition , 2016, Journal of Hematology & Oncology.

[9]  Zuojin Liu,et al.  Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma , 2016, Scientific Reports.

[10]  V. Janevski,et al.  Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment , 2015, Open access Macedonian journal of medical sciences.

[11]  J. Bruix,et al.  SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  K. Kairemo,et al.  [18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography Imaging in Oncology: Initial Staging and Evaluation of Cancer Therapy , 2013, Medical Principles and Practice.

[13]  Yangde Zhang,et al.  Hepatocellular Carcinoma: Focus on Different Aspects of Management , 2012, ISRN oncology.

[14]  Ki Lui,et al.  Potential Tumor Suppressive Role of Monoglyceride Lipase in Human Colorectal Cancer , 2012, Oncogene.

[15]  K. Tao,et al.  Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer. , 2011, Cancer letters.

[16]  J. Chang,et al.  Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. , 2011, Chemistry & biology.

[17]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[18]  S. Altekruse,et al.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Nicholas J Long,et al.  Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. , 2008, Angewandte Chemie.

[20]  J. Willmann,et al.  Molecular imaging in drug development , 2008, Nature Reviews Drug Discovery.

[21]  J. Marrero,et al.  Diagnosis and treatment of hepatocellular carcinoma. , 2008, Gastroenterology.

[22]  Pius August Schubiger,et al.  Molecular imaging with PET. , 2008, Chemical reviews.

[23]  M. Laeeq Khan,et al.  Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. , 2000, Journal of hepatology.

[24]  V J Lowe,et al.  Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. , 1995, The Annals of thoracic surgery.

[25]  Y Yonekura,et al.  In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  G. D’Amico,et al.  Survival and prognostic indicators in compensated and decompensated cirrhosis , 1986, Digestive Diseases and Sciences.